DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Funding Opportunity Number: HT942526TBIPHRPCTA
About the Opportunity
The fiscal year 2026 (FY26) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Clinical Trial Award (CTA) supports clinical trials with the potential to significantly impact psychological health conditions and/or traumatic brain injury (TBI) through clinical applications, including healthcare products, technologies, and/or practice guidelines.
Funding from this award must support a clinical trial evaluating interventions such as new drugs, biologics, medical devices, diagnostics, therapies, and behavioral health strategies. Preliminary data are required, and community-based participatory research (CBPR) approaches must be included.
Eligible applicants include any type of entity, with no cost-sharing or matching requirement. The program expects to make approximately 6 awards, with an estimated total funding of $18,600,000.
Research Levels
- Research Level 1: Supports proof-of-principle pilot studies, as well as phase 1 and phase 2 clinical trials.
- Research Level 2: Supports larger-scale and advanced clinical trials evaluating effectiveness in relevant patient populations.
Early-Career Investigator Partnering Option
Available for both Research Levels, this option accommodates two Principal Investigators (PIs), one of whom is an Early-Career Investigator. If recommended for funding, each PI will receive a separate award.
Key Dates
- Posted Date: May 21, 2026
- Application Deadline: October 15, 2026
- Archive Date: November 14, 2026
Contact Information
For assistance, contact the eBRAP Help Desk at 301-682-5507 or help@eBRAP.org.